Left Ventricular DysfunctionQuality of RecoveryRight Ventricular Dysfunction
Investigational drug(s) / intervention(s)
Maltodextrin solutionPlacebo solution
Maltodextrin solution: The oral preparation of 50 grams of Maltodextrin solution mixed in 400 mL of water
Placebo solution: Specifically formulated placebo to provide a similar taste and texture to Maltodextrin, without the same carbohydrate characteristics
Study summary
A randomized, controlled, double-blinded clinical trial evaluating the effect of the administration of a Maltodextrin solution on cardiac function in patients presenting for coronary artery bypass grafting surgery with a reduced left ventricular ejection fraction.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* 18 years of age or older
* Presenting for coronary artery bypass grafting surgery
* Preoperative left ventricular ejection fraction \< 50%
* First case of the day (7:30am start time)
Exclusion Criteria:
* Dysphagia, gastroparesis
* Cannot tolerate oral intake
* Celiac disease
* Type 1 diabetes
Primary outcome measure(s)
Intraoperative three-dimensional left ventricular ejection fraction (3-D LVEF) — After induction of anesthesia, prior to the start of surgery, and at the conclusion of surgery, just after chest closure LVEF as measured from a 3-D dataset
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.